Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan

Evidence of BNT126b2 vaccine effectiveness and breakthrough has been primarily demonstrated in populations outside of Asia; studies in the Western Pacific region are limited. Our retrospective cohort study assessed SARS-CoV-2 cases after vaccine rollout starting from mid-March 2021 at a tertiary hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Naito, Toshio, Yan, Yan, Tabe, Yoko, Seyama, Kuniaki, Deshpande, Gautam A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Coronavirus – Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500301/
https://www.ncbi.nlm.nih.gov/pubmed/34614387
http://dx.doi.org/10.1080/21645515.2021.1984124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500301/
https://www.ncbi.nlm.nih.gov/pubmed/34614387
http://dx.doi.org/10.1080/21645515.2021.1984124

Ejemplares similares